Author:
Yvonne Loh Su,Ratnagopal Pavanni,Patrick Tan Huat,Goh Yeow,Mickey Koh Boon,Koh Liang,Linn Yeh,Khee Hwang William
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Saccardi R, Mancardi GL, Solari A, et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood. 2005;105:2601-2607.
2. Healey KM, Pavletic SZ, Al-Omaishi J, et al. Discordant functional and inflammatory parameters in multiple sclerosis patients after autologous haematopoietic stem cell transplantation. Mult Scler. 2004;10:284-289.
3. Nash RA, Bowen JD, McSweeney PA, et al. High-dose immuno-suppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood. 2003;102:2364-2372.
4. Rabusin M, Andolina M, Maximova N, et al. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease. Haematologica. 2000;85(11 Suppl):81-85.
5. Burt RK, Verda L, Statkute L, Omaya Y. Unique clinical aspects of hematopoietic stem cell transplantation for autoimmune disease. Curr Opin Organ Transplant. 2004;9:49-53.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献